Announcement: Botton-Champalimaud International Pancreatic Cancer Conference 2025

The second edition of the Botton-Champalimaud International Pancreatic Cancer Conference (BCIPCC) will take place from October 29th to November 1st, 2025, at the Botton-Champalimaud Pancreatic Cancer Centre in Lisbon.

Following the success of the inaugural 2024 conference, the event will again bring together global experts and healthcare professionals to discuss the latest advancements in pancreatic cancer diagnosis, treatment, and care. Topics will include innovative diagnostic techniques, emerging therapies, and cutting-edge research.

Have a look at the program!

More information and registration: https://www.bcipcc.org

Lastest news

ALIPANC researchers organized the Symposium “Pancreatic Cancer: challenges and future perspectives”.

On September 17, at the Ramón Areces Foundation headquarters, Mariano Barbacid and Carmen Guerra, researchers at the...

Next week: Conference “Pancreatic Cancer: Challenges and future perspectives” in Madrid

On September 17th, the conference "Pancreatic Cancer: challenges and future perspectives" will take place at the Ramón...

Tumor Treating Fields with Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-label, pivotal phase III PANOVA-trial. Babiker et al.

At the 2025 ASCO congress it was presented the positive results of the PANOVA-3 trial. This is the first and...

Lastest news

ALIPANC researchers organized the Symposium “Pancreatic Cancer: challenges and future perspectives”.

Next week: Conference “Pancreatic Cancer: Challenges and future perspectives” in Madrid

Tumor Treating Fields with Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-label, pivotal phase III PANOVA-trial. Babiker et al.

Contact

Legal Terms